Arcadia Biosciences (RKDA) Misses Q2 EPS by 326c

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($3.26). Revenue for the quarter came in at $1.45 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Alphabet added to Dow Jones Industrial Average, Verizon dropped
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal